ZA961795B - Pharmaceuticals - Google Patents
PharmaceuticalsInfo
- Publication number
- ZA961795B ZA961795B ZA961795A ZA961795A ZA961795B ZA 961795 B ZA961795 B ZA 961795B ZA 961795 A ZA961795 A ZA 961795A ZA 961795 A ZA961795 A ZA 961795A ZA 961795 B ZA961795 B ZA 961795B
- Authority
- ZA
- South Africa
- Prior art keywords
- pharmaceuticals
- bioprecursor
- hhv
- medicament
- infection
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 2
- 229910019142 PO4 Inorganic materials 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 206010066435 human herpesvirus 8 infection Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000010452 phosphate Substances 0.000 abstract 1
- -1 phosphate ester Chemical class 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Transplantation (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9504497.0A GB9504497D0 (en) | 1995-03-07 | 1995-03-07 | Pharmaceuticals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA961795B true ZA961795B (en) | 1996-11-25 |
Family
ID=10770731
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA961795A ZA961795B (en) | 1995-03-07 | 1996-03-05 | Pharmaceuticals |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US6489330B1 (cs) |
| EP (1) | EP0814813B1 (cs) |
| JP (2) | JPH11501625A (cs) |
| KR (1) | KR19980702833A (cs) |
| CN (1) | CN1138545C (cs) |
| AT (1) | ATE254919T1 (cs) |
| AU (1) | AU701739B2 (cs) |
| BR (1) | BR9607663A (cs) |
| CA (1) | CA2214406C (cs) |
| CY (1) | CY2525B1 (cs) |
| CZ (1) | CZ293470B6 (cs) |
| DE (1) | DE69630876T2 (cs) |
| DK (1) | DK0814813T3 (cs) |
| ES (1) | ES2211949T3 (cs) |
| GB (1) | GB9504497D0 (cs) |
| HU (1) | HU226005B1 (cs) |
| NO (1) | NO317733B1 (cs) |
| NZ (1) | NZ303951A (cs) |
| PT (1) | PT814813E (cs) |
| TR (1) | TR199700921T1 (cs) |
| WO (1) | WO1996027378A2 (cs) |
| ZA (1) | ZA961795B (cs) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101594878A (zh) | 2006-09-18 | 2009-12-02 | 雷普特药品公司 | 通过给予受体相关蛋白（rap）-缀合物对肝病症的治疗 |
| CA2721148A1 (en) * | 2008-04-11 | 2009-10-15 | Epiphany Biosciences, Inc. | Treatment and/or prevention of multiple sclerosis |
| US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0141927B1 (en) * | 1983-08-18 | 1991-10-30 | Beecham Group Plc | Antiviral guanine derivatives |
| DE3582399D1 (de) * | 1984-09-20 | 1991-05-08 | Beecham Group Plc | Purin-derivate und ihre pharmazeutische verwendung. |
| DE3671227D1 (de) * | 1985-07-27 | 1990-06-21 | Beecham Group Plc | 9-substituierte guaninmonohydrate. |
| AU635642B2 (en) | 1990-05-24 | 1993-03-25 | E.R. Squibb & Sons, Inc. | Fluorinated bis(hydroxymethyl) cyclobutyl purines and pyrimidines |
| GB9015051D0 (en) | 1990-07-07 | 1990-08-29 | Beecham Group Plc | Pharmaceutical treatment |
-
1995
- 1995-03-07 GB GBGB9504497.0A patent/GB9504497D0/en active Pending
-
1996
- 1996-03-05 PT PT96907360T patent/PT814813E/pt unknown
- 1996-03-05 NZ NZ303951A patent/NZ303951A/xx not_active IP Right Cessation
- 1996-03-05 HU HU9800272A patent/HU226005B1/hu not_active IP Right Cessation
- 1996-03-05 EP EP96907360A patent/EP0814813B1/en not_active Expired - Lifetime
- 1996-03-05 CA CA2214406A patent/CA2214406C/en not_active Expired - Fee Related
- 1996-03-05 BR BR9607663A patent/BR9607663A/pt not_active Application Discontinuation
- 1996-03-05 ES ES96907360T patent/ES2211949T3/es not_active Expired - Lifetime
- 1996-03-05 WO PCT/EP1996/000933 patent/WO1996027378A2/en not_active Ceased
- 1996-03-05 DK DK96907360T patent/DK0814813T3/da active
- 1996-03-05 CZ CZ19972831A patent/CZ293470B6/cs not_active IP Right Cessation
- 1996-03-05 DE DE69630876T patent/DE69630876T2/de not_active Expired - Fee Related
- 1996-03-05 KR KR1019970706240A patent/KR19980702833A/ko not_active Ceased
- 1996-03-05 JP JP8526607A patent/JPH11501625A/ja not_active Withdrawn
- 1996-03-05 AU AU51022/96A patent/AU701739B2/en not_active Ceased
- 1996-03-05 ZA ZA961795A patent/ZA961795B/xx unknown
- 1996-03-05 CN CNB961937939A patent/CN1138545C/zh not_active Expired - Fee Related
- 1996-03-05 TR TR97/00921T patent/TR199700921T1/xx unknown
- 1996-03-05 AT AT96907360T patent/ATE254919T1/de not_active IP Right Cessation
-
1997
- 1997-09-05 NO NO19974101A patent/NO317733B1/no not_active IP Right Cessation
-
1999
- 1999-12-29 US US09/473,888 patent/US6489330B1/en not_active Expired - Lifetime
-
2005
- 2005-05-26 CY CY0500032A patent/CY2525B1/xx unknown
-
2007
- 2007-08-08 JP JP2007206799A patent/JP2007297412A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2216796A1 (en) | Quinazoline derivatives | |
| GEP20002298B (en) | Benzimidazole Derivatives, Method of Their Production, Pharmaceutical Composition Containing the Same and Method for Its Treatment | |
| NZ308518A (en) | Antibacterial cephalosporins | |
| BR9506552A (pt) | Método de inibição de integrase retroviral | |
| PT736029E (pt) | Sulfamatos de pseudofructopiranose anticonvulsivos | |
| GB9504497D0 (en) | Pharmaceuticals | |
| GB9323404D0 (en) | Pharmaceuticals | |
| KR930702978A (ko) | 인식력 장애의 치료 | |
| IL111138A (en) | Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia | |
| GB9323403D0 (en) | Pharmaceuticals | |
| AU7076494A (en) | Utilization of efaroxan and derivatives thereof for the preparation of a medicament intended to the treatment of parkinson disease | |
| NO167982C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive penemderivater. | |
| EP0784973A3 (en) | Quinoxaline derivatives for treating tinnitus | |
| AU1494395A (en) | The use of deoxyspergualin for preparing a pharmaceutical for treating hyperreactive inflammatory diseases | |
| MX9709438A (es) | Ester-amidas de acido 3-hidroxi-piridina-2-carboxilico, su preparacion y su utilizacion como medicamentos. |